Similar articles

• T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection.

  Gjertsen HA, Lundin KE, Hansen T, Thorsby E. Gjertsen HA, et al. Transpl Immunol. 1993;1(2):126-31. doi: 10.1016/0966-3274(93)90005-s. Transpl Immunol. 1993. PMID: 8081770
• Oncogene-derived peptides: a new class of tumor rejection antigens?

  Gedde-Dahl T 3rd, Olsen BH, Thorsby E, Gaudernack G. Gedde-Dahl T 3rd, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1385-6. Transplant Proc. 1993. PMID: 8442151 No abstract available.
• Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.

  Narimatsu H, Murata M, Terakura S, Sugimoto K, Naoe T. Narimatsu H, et al. Biol Blood Marrow Transplant. 2008 Apr;14(4):397-402. doi: 10.1016/j.bbmt.2008.01.001. Epub 2008 Feb 14. Biol Blood Marrow Transplant. 2008. PMID: 18342781
• [HLA mismatch and graft rejection].

  Matsuyoshi H, Senju S, Monji M, Nishimura Y. Matsuyoshi H, et al. Nihon Rinsho. 2005 Apr;63 Suppl 4:621-31. Nihon Rinsho. 2005. PMID: 15861720 Review. Japanese. No abstract available.
• The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.

  Waanders MM, Roelen DL, Brand A, Claas FH. Waanders MM, et al. Transfus Med Rev. 2005 Oct;19(4):281-7. doi: 10.1016/j.tmrv.2005.04.002. Transfus Med Rev. 2005. PMID: 16214017 Review.